Feb. 4, 2013
-- Cresset (http://www.cresset-
group.com/), innovative provider of computational chemistry software and consulting services, announces excellent 2012 sales figures and growth.
Dr Robert Scoffin, CEO of Cresset, says, “We are delighted to announce robust growth through 2012 in both our software and services divisions. We have invested in the rebranding of our software tools and now have an even more professional software workbench for medicinal and computational chemists. This is complemented by our growing Consulting Services division, including the first full year of operation of our innovative CompChem-on-
“The breadth and range of consulting projects that Cresset undertakes demonstrates the power and scope of Cresset’s underlying patented technology,”
says Dr Martin Slater, Head of Consulting. “We have completed consulting projects this year on research areas as diverse as virtual screening against a novel rheumatoid arthritis target and discovery of new sweeteners for a global drinks manufacturer.”
Dr Scoffin adds, “As companies increasingly choose to outsource computational chemistry in order to take advantage of just-in-time expertise, we expect Cresset to continue to enjoy outstanding growth throughout and beyond 2013.”About Cresset Group Ltd
Cresset develops software for calculating and comparing the molecular field characteristics of chemical compounds. Cresset also offers consultancy services which enable companies to outsource computational chemistry work to achieve high value, on-demand expertise, particularly in the areas of library design, virtual screening, scaffold hopping, lead optimization and patent analysis.
Cresset’s field technology uses the surface properties of molecules to evaluate their activities and properties, rather than relying on 2D structure similarity, which enables Cresset’s users to find more interesting, novel and relevant results than other methods. This field technology provides a smarter, structure independent way of hit-finding, lead switching and lead optimization in drug discovery and other chemistry-based research projects. Cresset’s field technologies have been successfully applied to a very wide range of target classes, with and without structural information, on over 100 projects for major pharmaceutical and biotechnology companies. www.cresset-group.com
For further information on the complete range of software and services available from Cresset, please visit www.cresset-
group.com, follow Cresset on Twitter (@cressetgroup (http://twitter.com/#!/cressetgroup
)) or join their LinkedIn group (http://www.linkedin.com/groups?gid=3036251&trk=hb_side_g